Skip to main content
GettyImages-1302894613-e1633710908871

Medicine's Mark Cameron weighs in on FDA's decision to approve booster doses for 12- to 15-year-olds

MEDIA | March 4, 2022
STORY BY: EDITORIAL STAFF

FDA approves use of Pfizer vaccine for those between 12 and 15 years old

Consumer Affairs: Mark Cameron, associate professor at the School of Medicine, discussed the FDA’s recent approval of booster doses of Pfizer’s COVID vaccine for children between 12 and 15 years of age.